Bini A, Salerno S, Protti S, Pollastro F, Profumo A, Morini L
Photochem Photobiol Sci. 2024; 23(7):1239-1249.
PMID: 38739326
DOI: 10.1007/s43630-024-00589-4.
Caprari C, Ferri E, Vandelli M, Citti C, Cannazza G
J Cannabis Res. 2024; 6(1):21.
PMID: 38702834
PMC: 11067227.
DOI: 10.1186/s42238-024-00226-y.
Seccamani P, Franco C, Protti S, Porta A, Profumo A, Caprioglio D
J Nat Prod. 2021; 84(11):2858-2865.
PMID: 34668704
PMC: 8765678.
DOI: 10.1021/acs.jnatprod.1c00567.
Watson J, Kim J, Das A
Prostaglandins Other Lipid Mediat. 2019; 143:106337.
PMID: 31085370
PMC: 6685292.
DOI: 10.1016/j.prostaglandins.2019.106337.
Di Marzo V
Nat Rev Drug Discov. 2018; 17(9):623-639.
PMID: 30116049
DOI: 10.1038/nrd.2018.115.
[Co-editors and editors with Jewish origins of the first German journals for anaesthesia. Their fate under National Socialism and an attempt at a biographical appreciation].
Goerig M, Goetz A
Anaesthesist. 2010; 59(9):818-41.
PMID: 20842476
DOI: 10.1007/s00101-010-1748-0.
Tetrahydrocannabinols.
Bull World Health Organ. 2010; 43 Suppl:95-8.
PMID: 20604384
PMC: 2427610.
Equidistance concept and structure-activity relationship of curarizing drugs.
LOEWE S, Harvey S
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1952; 214(2):214-26.
PMID: 14953228
DOI: 10.1007/BF00246056.
Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F
Clin Pharmacokinet. 2003; 42(4):327-60.
PMID: 12648025
DOI: 10.2165/00003088-200342040-00003.
Psychopharmacological activity of the active constituents of hashish and some related cannabinoids.
Grunfeld Y, Edery H
Psychopharmacologia. 1969; 14(3):200-10.
PMID: 4981896
DOI: 10.1007/BF00404218.
Are biogenic amines involved in the mechanism of action of the tetrahydrocannabinols?.
DAGIRMANJIAN R, HODGE H
Agents Actions. 1969; 1(2):46-8.
PMID: 4938305
DOI: 10.1007/BF01977666.
Effects of (--)delta-9-trans-tetrahydrocannabinol in man.
ISBELL H, Gorodetzsky C, Jasinski D, Claussen U, von Spulak F, Korte F
Psychopharmacologia. 1967; 11(2):184-8.
PMID: 4871478
DOI: 10.1007/BF00401256.
[Hashish--chemistry and problems].
Bieniek D, Gau W, Korte F
Naturwissenschaften. 1974; 61(3):117-21.
PMID: 4826363
DOI: 10.1007/BF00606280.
Lack of tolerance to the effect of two tetrahydrocannabinols on aggressiveness.
ten Ham M, VAN NOORDWIJK J
Psychopharmacologia. 1973; 29(2):171-6.
PMID: 4736260
DOI: 10.1007/BF00422649.
Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
Rating D, Broermann I, Honecker H, Kluwe S, Coper H
Psychopharmacologia. 1972; 27(4):349-57.
PMID: 4648618
DOI: 10.1007/BF00429388.
Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat.
Fernandes M, Schabarek A, Coper H, Hill R
Psychopharmacologia. 1974; 38(4):329-38.
PMID: 4473791
DOI: 10.1007/BF00429130.
Cannabinoids and hexobarbital induced loss of righting reflexes.
Fernandes M, Kluwe S, Coper H
Naunyn Schmiedebergs Arch Pharmacol. 1974; 283(4):431-5.
PMID: 4278425
DOI: 10.1007/BF00501116.
The effect of cannabinol delta1-tetrahydro-cannabinol clearance from the blood.
McCallum N
Experientia. 1975; 31(8):957-8.
PMID: 1157869
DOI: 10.1007/BF02358875.
